Recruiting Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: NCT06322238 Conditions Drug Metabolism, Poor, CYP2C19-Related, Drug Metabolism, Poor, CYP2D6-Related, Ineffective Drug Action, +2 more Locations Mayo Clinic — Rochester, Minnesota, United States View Trial Details
